Article Versions Notes

Varotto-Boccazzi I, Garziano M, Cattaneo GM, Bisaglia B, Gabrieli P, Biasin M, Manenti A, Rubolini D, Clerici M, Montomoli E, et al. Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein. Vaccines. 2022; 10(5):803. https://doi.org/10.3390/vaccines10050803

Varotto-Boccazzi, Ilaria, Micaela Garziano, Giulia Maria Cattaneo, Beatrice Bisaglia, Paolo Gabrieli, Mara Biasin, Alessandro Manenti, Diego Rubolini, Mario Clerici, Emanuele Montomoli, and et al. 2022. "Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein" Vaccines 10, no. 5: 803. https://doi.org/10.3390/vaccines10050803

Varotto-Boccazzi, I., Garziano, M., Cattaneo, G. M., Bisaglia, B., Gabrieli, P., Biasin, M., Manenti, A., Rubolini, D., Clerici, M., Montomoli, E., Zuccotti, G. V., Trabattoni, D., Epis, S., & Bandi, C. (2022). Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein. Vaccines, 10(5), 803. https://doi.org/10.3390/vaccines10050803